97 related articles for article (PubMed ID: 25976257)
21. Pathophysiological evaluation of pilocytic astrocytoma in adults: Histopathological and immunohistochemical analysis.
Santino SF; Salles D; Stávale JN; Malinverni ACM
Pathol Res Pract; 2023 Aug; 248():154593. PubMed ID: 37331182
[TBL] [Abstract][Full Text] [Related]
22. Oncogenic KIAA1549-BRAF fusion with activation of the MAPK/ERK pathway in pediatric oligodendrogliomas.
Kumar A; Pathak P; Purkait S; Faruq M; Jha P; Mallick S; Suri V; Sharma MC; Suri A; Sarkar C
Cancer Genet; 2015 Mar; 208(3):91-5. PubMed ID: 25794445
[TBL] [Abstract][Full Text] [Related]
23. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.
Korshunov A; Meyer J; Capper D; Christians A; Remke M; Witt H; Pfister S; von Deimling A; Hartmann C
Acta Neuropathol; 2009 Sep; 118(3):401-5. PubMed ID: 19543740
[TBL] [Abstract][Full Text] [Related]
24. Alterations of BRAF and HIPK2 loci predominate in sporadic pilocytic astrocytoma.
Yu J; Deshmukh H; Gutmann RJ; Emnett RJ; Rodriguez FJ; Watson MA; Nagarajan R; Gutmann DH
Neurology; 2009 Nov; 73(19):1526-31. PubMed ID: 19794125
[TBL] [Abstract][Full Text] [Related]
25. BRAF Fusion Analysis in Pilocytic Astrocytomas: KIAA1549-BRAF 15-9 Fusions Are More Frequent in the Midline Than Within the Cerebellum.
Faulkner C; Ellis HP; Shaw A; Penman C; Palmer A; Wragg C; Greenslade M; Haynes HR; Williams H; Lowis S; White P; Williams M; Capper D; Kurian KM
J Neuropathol Exp Neurol; 2015 Sep; 74(9):867-72. PubMed ID: 26222501
[TBL] [Abstract][Full Text] [Related]
26. Molecular biomarkers in pediatric glial tumors: a needed wind of change.
Fontebasso AM; Bechet D; Jabado N
Curr Opin Oncol; 2013 Nov; 25(6):665-73. PubMed ID: 24097106
[TBL] [Abstract][Full Text] [Related]
27. The involvement of the MAPK pathway in pilocytic astrocytomas.
Salles D; Santino SF; Ribeiro DA; Malinverni ACM; Stávale JN
Pathol Res Pract; 2022 Apr; 232():153821. PubMed ID: 35231859
[TBL] [Abstract][Full Text] [Related]
28. Pilocytic astrocytoma: pathology, molecular mechanisms and markers.
Collins VP; Jones DT; Giannini C
Acta Neuropathol; 2015 Jun; 129(6):775-88. PubMed ID: 25792358
[TBL] [Abstract][Full Text] [Related]
29. [Clinicopathological Study of Pilomyxoid-Spectrum Astrocytomas:An Analysis of the BRAF Gene. Report of Two Cases].
Ito T; Sato K; Oikawa M; Sugio H; Asanome T; Ozaki Y; Nakamura H; Tanaka S; Tsuda M; Nagashima K
No Shinkei Geka; 2015 Sep; 43(9):825-33. PubMed ID: 26321697
[TBL] [Abstract][Full Text] [Related]
30. Adult pilocytic astrocytoma in the molecular era: a comprehensive review.
Gregory TA; Chumbley LB; Henson JW; Theeler BJ
CNS Oncol; 2021 Mar; 10(1):CNS68. PubMed ID: 33448230
[TBL] [Abstract][Full Text] [Related]
31. Recurrent somatic BRAF insertion (p.V504_R506dup): a tumor marker and a potential therapeutic target in pilocytic astrocytoma.
Khater F; Langlois S; Cassart P; Roy AM; Lajoie M; Healy J; Richer C; St-Onge P; Piché N; Perreault S; Cellot S; Marzouki M; Jabado N; Sinnett D
Oncogene; 2019 Apr; 38(16):2994-3002. PubMed ID: 30575814
[TBL] [Abstract][Full Text] [Related]
32. Adult with cerebellar anaplastic pilocytic astrocytoma associated with BRAF V600E mutation and p16 loss.
Yeo YH; Byrne NP; Counelis GJ; Perry A
Clin Neuropathol; 2013; 32(3):159-64. PubMed ID: 23196000
[TBL] [Abstract][Full Text] [Related]
33. Pathologic characteristics of pediatric intracranial pilocytic astrocytomas and their impact on outcome in 3 countries: a multi-institutional study.
Tihan T; Ersen A; Qaddoumi I; Sughayer MA; Tolunay S; Al-Hussaini M; Phillips J; Gupta N; Goldhoff P; Baneerjee A
Am J Surg Pathol; 2012 Jan; 36(1):43-55. PubMed ID: 21989351
[TBL] [Abstract][Full Text] [Related]
34. The molecular and cell biology of pediatric low-grade gliomas.
Chen YH; Gutmann DH
Oncogene; 2014 Apr; 33(16):2019-26. PubMed ID: 23624918
[TBL] [Abstract][Full Text] [Related]
35. Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.
Hargrave D
Br J Neurosurg; 2009 Aug; 23(4):351-63. PubMed ID: 19637006
[TBL] [Abstract][Full Text] [Related]
36. MAPK pathway activation and the origins of pediatric low-grade astrocytomas.
Tatevossian RG; Lawson AR; Forshew T; Hindley GF; Ellison DW; Sheer D
J Cell Physiol; 2010 Mar; 222(3):509-14. PubMed ID: 19937730
[TBL] [Abstract][Full Text] [Related]
37. Sensitive determination of BRAF copy number in clinical samples by pyrosequencing.
Setty P; Gessi M; Waha A; Hammes J; El-Maarri O; Pietsch T; Waha A
Diagn Mol Pathol; 2011 Sep; 20(3):148-57. PubMed ID: 21817898
[TBL] [Abstract][Full Text] [Related]
38. Adult recurrent pilocytic astrocytoma: Clinical, histopathological and molecular study.
Trabelsi S; Mama N; Ladib M; Popov S; Burford A; Mokni M; Tlili K; Krifa H; Varella-Garcia M; Jones C; Tahar Yacoubi M; Saad A; H'mida Ben Brahim D
Neurochirurgie; 2015 Dec; 61(6):392-7. PubMed ID: 26597605
[TBL] [Abstract][Full Text] [Related]
39. The morphologic and molecular characteristics of pilocytic astrocytomas and the role of MAPK pathway: what does not kill you makes you stronger.
Aktas ON; Tihan T
Adv Anat Pathol; 2014 Mar; 21(2):144-50. PubMed ID: 24508697
[TBL] [Abstract][Full Text] [Related]
40. KIAA1549:BRAF fusion gene in pediatric brain tumors of various histogenesis.
Antonelli M; Badiali M; Moi L; Buttarelli FR; Baldi C; Massimino M; Sanson M; Giangaspero F
Pediatr Blood Cancer; 2015 Apr; 62(4):724-7. PubMed ID: 25382612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
